Delivery Order SPE2DB20D1109-SPE2DB25FN60V

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $19,408.80 and an ultimate completion date of August 22, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $14,826.60 and was awarded on January 3, 2022, with a completion date of January 4, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Boostrix TDAP vaccine syringes. The contract has a ceiling value of $22,017.96 and a completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of BOOSTRIX TDAP Vaccine Syringes 0.5 mL. The contract has a total ceiling value of $1,288.90 and a completion date of September 27, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of the company's extensive federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $6,225.12 and a completion date of January 8, 2025. It is a firm-fixed-price contract without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP vaccine syringes 0.5mL, with a ceiling value of $3,028.66 and a performance period through November 2024. The contract is a firm fixed-price arrangement and does not have any set-aside designations. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $8,827.40 and is a firm fixed price contract. The period of performance runs through September 12, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $4,621.48 and an ultimate completion date of August 27, 2024. It is a firm fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Boostrix TDAP vaccine syringes. The order has a ceiling value of $24,357.24 and will be delivered by September 17, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BOOSTRIX TDAP vaccine syringes. The contract is a firm-fixed-price, indefinite delivery vehicle valued at up to $12,654.00, with a period of performance through July 2024. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor responsible for providing these critical medical supplies to support federal...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN60V
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $9,579.60 and an ultimate completion date of February 25, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 3:13 AM